Effect of equimolar amounts of long-chain triglycerides and medium-chain triglycerides on small-bowel transit time in humans by Ledeboer, M. et al.






The following full text is a publisher's version.
 
 





Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
omh ii()7i/i>r»/iiM)i-t)(){}n$oa,t)i>/(>
JOlUtNAL <»K 1’AIWNTKKAI. AND NNTKHAI. NllTHlTKlN
Copyright UH)fi by tht» AnH*rir:m Soridy (or I’umtforul mui Kntcral Nutrition
Vul, 1 ï», N«i. 1 
Printed in U.S.A.
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ABSTRACT. Background; The use of medium-chain 
triglycerides in diet« is limited by the frequent occurrence 
of diarrhea or crampy abdominal pain. Because these 
symptoms may result from an accéléraied transit lime induced 
by medium-chain triglycerides, we investigated the effect of 
equimolar amounts of long-chain triglycerides and medium- 
chain triglycerides on small-bowel transit time in 10 healthy 
subjects. Methods: Small-bowel transit time was measured by 
the lactulose hydrogen breath test after intraduodenal 
administration of lactulose. Results: Intraduodenal administra­
tion of 20 mmol of long-chain triglycerides per hour for 00 
minutes did not alter small-bowel transit time compared with 
control (77 :f* 11 minutes vs 77 f: 10 minutes, respectively), 
whereas intraduodenal infusion of an equimolar dose of 
medium-chain triglycerides significantly accelerated small- 
bowel transit, time (RM * t> minutes) compared with long-chain
triglycerides mul control (ƒ; <  .05). In six individuals, 
small-bowel transit time was shorter during the administration 
of medium-chain triglycerides compared with control, and 
three of these subjects experienced abdominal symptoms, 
Plasma choleeystokinin levels increased significantly (p < 
.05) during the administration of long-chain triglycerides, from 
2.0 :t O.li pmol/L to a maximum of 4.14 ± 0.0 pmol/L No 
significant alterations were observed in plasma cholecystok- 
inin levels during administration of medium-chain triglycerides 
or in the control experiment. Conclusions: Although it; 
significantly increases choleeystokinin secretion, the intraduo­
denal infusion of long-chain triglycerides does not affect 
small-bowel transit time, whereas the infusion of medium- 
chain triglycerides accelerates small-bowel transit limes 
independent of cholecystokinin. (Journal of Parenteral and  
Enteral Nutrition 10:5-8, 1095)
Medium-chain triglycerides contain laity acids with a 
c‘hain length varying from (i to 12 carbon atoms. 
Compared with long-cluun triglycerides, these tri­
glycerides exhibit some favorable physicochemical char­
acteristics that result in rapid intraluminal hydrolysis 
and absorption. Medium-chain triglycerides art' therefore 
attractive as a caloric source for patients wit.li impaired 
fat digestion or absorption. However, the use of 
medium-chain triglycerides in diets is limited by the 
frequent occurrence of gastrointestinal symptoms such 
as borborygmi, crampy abdominal pain, and diarrhea, 
It has been suggested that the diarrhea is secondary to 
the rapid hydrolysis of modium-ehain triglycerides, and 
if results in the formation of osmotieaily active fatty 
acids.1 :l Although I ho gastrointestinal symptoms occur­
ring after medium-chain triglyceride ingestion could be 
explained by an accelerated intestinal transit, this 
possibility has never been investigated. Therefore, the 
aim of the present study was to determine the effect« 
of equimolar amounts of long-chain and medium-chain 
triglycerides on small-bowel transit, time'. To exclude 
the influence of variable gastric emptying, small-bowel 
transit time was measured during intraduodenal admini­
stration of fat, using the lactulose hydrogen breath test 
after intraduodenal administration of lactulose/1 
A second aim of the study was to investigate the 
role of cholecystokinin on small-bowel transit time 
inasmuch as cholecystokinin is released after ingestion 
of long-chain triglycerides but not aft,or ingestion of 
medium-chain triglycerides/’
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Ton healthy subject« (seven men, three' women) (mean 
ages 25 years; range, 19 to iii) years) wore studied. 
Informed consent was obtained from each individual, 
and the protocol was approved by the ethical committee 
of the Leiden University Hospital. None of the subject« 
bad a history of ga«trointestinal symptoms or surgery, 
and none were taking drugs that; could possibly influence 
gastrointestinal motility or the intestinal flora.
Test Procedure
Each subject participated in three experiment« per­
formed on separate occasions in random order with an 
interval of at least; 7 days. After an overnight fast, the 
subjects were intubated at 8  am  with a single-lumen 
polyurethane feeding tube (Flocare OhlO, Nutrieia, 
Zoolermoor, The Netherlands) that was positioned under 
fluoroscopic* control in the horizontal part of the
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duodenum. An IV cannula was inserted into an 
antecubital vein of one arm for blood sampling.
Basal blood and breath samples were obtained at 30, 
15 and 0 minutes before the start of the experiment. 
The experiment was started within 2 minutes by 
administration of 6 g of lactulose (Legendal; Inpharzam, 
Amersfoort, The Netherlands) in 70 mL of water 
(osmolality,' 280 mOsm/kg) into the duodenum to 
determine small-bowel transit time by hydrogen breath 
analysis. Thereafter, intraduodenal infusion was started 
with long-chain triglycerides (com oil, 93% C16-C18), 
medium-chain triglycerides (Ceres medium-chain 
triglycerides dietary oil, 98% C8-C10) (Van den Bergh 
en Jurgens BV, Rotterdam, The Netherlands), or saline 
(control) at an infusion rate of 20 mmol/h for 90 minutes 
(medium-chain triglycerides, 15 g for 90 minutes; 
long-chain triglycerides, 30 g for 90 minutes).
Small-Bowel Transit Time
Small-bowel transit time was determined by lactulose 
hydrogen breath analysis, as described by Bond and 
Levitt.4 Hydrogen gas is generated by bacterial flora 
from unabsorbed carbohydrates in the colon.1 Arrival 
of the nonabsorbable carbohydrate lactulose in the colon 
can be detected by an increase in pulmonary hydrogen 
excretion. Samples of end-expiratory breath were taken 
under basal conditions and every 5 minutes after 
intraduodenal lactulose administration until a sustained 
increase in breath hydrogen excretion was observed. 
The samples were collected in 25-mL plastic syringes 
and were immediately analyzed in a hydrogen breath-test 
unit (Lactoscreen, Hoekloos, The Netherlands). Small- 
bowel transit time was defined as the time between 
lactulose administration and a sustained rise in breath 
hydrogen concentration of at least 10 ppm above basal 
level. In our department, the mean coefficient of variation 
for duodenocecal transit time using the lactulose 
hydrogen breath test with 6 g of lactulose is 12% ± 5%.
Blood Samples
Blood samples for determination of plasma 
cholecystokinin levels were obtained at 15-minute 
intervals, starting from time -30 minutes to 120 minutes. 
Blood samples were collected in tubes containing EDTA 
and were kept on ice during the experiment. Plasma 
cholecystokinin was determined by a sensitive and specific 
radioimmunoassay that used antibody Tan.7,8 This antibody 
binds to all carboxy-terminal cholecystokinin peptides 
containing the sulfated tyrosyl region. The detection limit 
of the assay was 0.5 pmol per liter of plasma The intra-assay 
variation ranged from 4.6% to 11.5%, and the interassay 
variation ranged from 11.3% to 26.1%.8
Statistical Analysis
The results are expressed as mean ± SEM. Plasma 
cholecystokinin levels are expressed in picomoles per 
liter. Differences in small-bowel transit time and in 
plasma cholecystokinin levels between the three treat­
ment groups, and for plasma cholecystokinin levels 
within the three groups, were analyzed for significance
of difference by analysis of variance. When this indicated 
a probability of less than 0.05 for the null hypothesis, 
Student’s Newman-Keuls analyses were performed to 
determine which values differed significantly. The 
significance level was set. at p < .05.
RESULTS
Small-Bowel Transit Time
Pasting hydrogen breath levels were below 12 ppm 
in all subjects. A sustained increase in the pulmonary 
hydrogen secretion of 10 ppm after administration of 
lactulose was observed in all subjects. Mean small-bowel 
transit time during intraduodenal infusion of saline was 
77 ± 10 minutes. The transit time during infusion of 
long-chain triglycerides (77 ± 11 minutes) was not 
significantly different and was identical with that; 
observed in the control experiment. Administration of 
medium-chain triglycerides, however, resulted in a 
significant acceleration of transit time (59 ± li minutes) 
compared with transit time after administration of 
long-chain triglycerides and of saline (ƒ> < .05). The 
individual data of the transit times are presented in 
Table I and Figure 1. Compared with saline infusion, 
small-bowel transit time was accelerated during admini­
stration of medium-chain triglycerides in six subjects 
and was equal in three subjects; small-bowel transit 
time was prolonged in one subject. Three of the six 
subjects with an accelerated small-bowel transit time 
experienced mild symptoms of borbotygmi and diarrhea 
after administration of medium-chain triglycerides. Com­
pared with administration of long-chain triglycerides, 
small-bowel transit, time was accelerated during admini­
stration of medium-chain triglycerides in seven subjects 
and was equal in two subjects; small-bowel transit time 
was prolonged in one subject;. No side effect« were 
reported after administration of long-chain triglycerides 
or saline infusion.
Plasma Cholecystokinin Levels
Fasting plasma cholecystokinin levels wen1 not 
significantly different among the three experiments: 
long-chain triglycerides, 2.0 ± 0.3 pmol/L; medium-chain 
triglycerides, 2.5 ± 0.3 pmol/L; and saline 2.5 t  (),;! 
pmol/L (Fig, 2). Administration of long-chain triglycerides 
from time 0 to 90 minutes resulted in a significant ( p 
<  .05) increase in plasma cholecystokinin over basal 
level starting from time 15 minutes until 105 minutes. 
Plasma cholecystokinin levels during administration of 
long-chain triglycerides rose to a maximum of 4.;i 
0.6 pmol/L at 75 minutes. Administration of long-chain 
triglycerides significantly (p  <  .05) increased plasma 
cholecystokinin levels from lime 15 minutes to 105 
minutes compared with control. No significant alteration 
in plasma cholecystokinin levels over basal was obscured 
during administration of medium-chain triglycerides.
DISCUSSION
The present study shows that intraduodenal infusion 
of medium-chain triglyceride oil, as measured by 
lactulose hydrogen breath testing, significantly aceeler-
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ates small-bowel transit time compared with that, soon 
in control subjects, Individual data showed that, small- 
bowol transit time was shorter during administration of 
medium-chain triglycerides in six subjects compared 
with control subjects; in three subjects, small-bowel 
transit time was equal, and in one subject, it; was 
prolonged, In contrast:, mi equimolar amount of long- 
c*hain triglycerides administrated intraduodonally did not 
significantly affect small-bowel transit lime. This finding 
confirms a previous observation by Read et al1’ that 
intrajejunal atlministration of a long-ehain triglyceride 
emulsion does not change small-bowel transit time, 
compared with that in control subjects. To our 
knowledge, the effect of medium-chain triglycerides on 
small-bowel transit time has not, been investigated 
previously,
The physicochemical characteristics of medium-chain 
triglycerides reveal import,¿ml implications for their 
digestion and absorption. It has been suggested that 
medimn-ohain triglycerides are more* rapidly hydrolyzed 
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the hydrolysis of long-ehain triglycerides,1 :t which is 
thought to be caused by pancreatic enzymes that are 
secreted in response to long-ehain triglyceride-stimulated 
cholecystokiniu release. In contrast to long-chain 
triglycerides, medium-chain triglycerides do not affect 
plasma cholecystokinin levels. Hydrolysis of medium- 
chain triglycerides may he caused by nonpanereatie 
lipases (('specially gastric lipase), which account, for as 
much as 15% of total lipolytic activity at: the ligament; 
of Treitz.1,1,11 In addition to the more rapid hydrolysis 
of medium-chain triglycerides, dispersion of medium- 
chain triglycerides can be achieved in the absence of 
bile salts. Small amounts of medium-chain triglycerides 
are able to enter the intestinal cell without prior 
hydrolysis. Transport of medium-chain fatty acids occurs 
without chylomicron formation through the portal vein. 
The mechanism responsible for the accelerated transit 
time by medium-chain triglycerides is not apparent; 
however, several mechanisms may be involved. It has 
been suggested that rapid hydrolysis of medium-chain 
triglycerides may lead to the formation of osmotieally 
active fatty acids that increase flow' through the .small 
intestine.1 :l Alternatively, medium-chain triglycerides 
induce a direct secretory response of the small intestine. 
A third mechanism that, might explain the accelerated 
transit; time is an alteration in small intestine motility. 
During the fasting period, a recurrent cyclic pattern of 
myoelectric activity, the interdigestive migrating myoelec­
tric complex, is observed in the small intestine.12,1:1 This
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fasting pattern is disrupted by the ingestion of food, 
the constituents of which (especially fat) are capable 
of inducing a prolonged feeding pattern.14’15 In dogs, 
medium-chain triglycerides potently disrupt the interdiges- 
tive migrating myoelectric complex to a feeding pattern.14 
In humans, however, a medium-chain triglyceride-oligopep- 
tide mixture induces a motor pattern similar to the 
interdigestive migrating myoelectric complex.10 This may 
be explained by the inability of medium-chain 
triglycerides to stimulate cholecystoldnin secretion, 
inasmuch as cholecystokinin is thought to be one of 
the hormonal factors involved in the conversion from 
a fasting to a fed motility pattern.17
The effect of cholecystoldnin on intestinal transit time 
is not fully understood. It has been reported that infusion 
of a cholecystoldnin octapeptide accelerates intestinal 
transit.18 However, loxiglumide, the specific cholecystok­
inin receptor antagonist, does not affect small-bowel 
transit time as measured by lactulose hydrogen breath 
testing.19 In contrast to this observation is a recent 
report by Schmidt et al20 that demonstrates a prolonged 
orocecal transit time during loxiglumide infusion. Be­
cause loxiglumide accelerates gastric emptying, the 
prolonged orocecal transit time is thought to result from 
a delay in small-bowel transit during cholecystoldnin- 
receptor blockade. Although in the present study 
endogenous cholecystokinin secretion was stimulated 
by intraduodena] long-chain triglycerides, no significant 
alteration in small-bowel transit time during infusion of 
long-chain triglycerides was observed. On the other 
hand, intraduodenal medium-chain triglycerides signifi­
cantly accelerated small-bowel transit time without 
affecting cholecystoldnin secretion, indicating that the 
effect of medium-chain triglycerides on small-bowel 
transit time is independent of cholecystokinin. Our 
observation that medium-chain triglycerides do not 
stimulate cholecystokinin secretion is in agreement with 
previous findings.5
We conclude that intraduodenal infusion of long-chain 
triglycerides does not affect small-bowel transit time, 
although it significantly increases cholecystoldnin secre­
tion, whereas infusion of medium-chain triglycerides 
significantly accelerates small-bowel transit time, inde­
pendent of cholecystoldnin.
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